author-photo

Michael W. Schmitt

Seattle Genetics

2

Papers

4

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (PDAC) (trial in progress).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)